MedPath

Rinobact Spray

Brand Name: Rinobact Spray

Generic Name: Xylometazoline Hydrochloride + Lysozyme Hydrochloride

Active
Registration Number

DRP-12714

Dosage Form

Nasal Spray Solution

Issuance Date

September 28, 2022

Expiry Date

September 28, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 mg/ 0.5 mg per mL
PackagingAmber Glass Bottle with Nasal Spray and Protective Cap x 10 mL (Box of l's)

Classification

C
Classification
Over-the-Counter (OTC)
P
Pharmacologic
Nasal Decongestant/ Anti-inflammatory
A
Application
Initial TOTC)
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Xylometazoline HydrochlorideActive
Monograph: Xylometazoline
Lysozyme HydrochlorideActive
Monograph: Lysozyme

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.